New research from the University of Michigan Comprehensive Cancer Center finds that the protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative - and that the drug Herceptin, which targets HER2, may have an even greater role for treating breast cancer and preventing its spread.
http://www.eurekalert.org/pub_releases/2013-02/uomh-usc022113.php
http://www.eurekalert.org/pub_releases/2013-02/uomh-usc022113.php
No comments:
Post a Comment